VJHemOnc is committed to improving our service to you

SOHO Italy 2020 | CLL: state of the art in Italy

VJHemOnc is committed to improving our service to you

Antonio Cuneo

Antonio Cuneo, MD, PhD, University of Ferrara, Ferrara, Italy, discusses the treatment of chronic lymphocytic leukemia (CLL) in Italy, including the use of prognostic and predictive biomarkers in patient counseling and precision medicine, where the mutational profile is used for risk stratification in CLL patients as well as informing treatment with targeted agents such as ibrutinib and venetoclax. Dr Cuneo also outlines treatment approaches to relapsed patients and highlights challenges in choosing therapies for these patients, as well as the importance of understanding patients’ associated comorbities. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter